Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
RESEARCH TOOLSreports
Holding MRVI?
Track your performance easily
See the Price Targets and Ratings of:
MRVI Analyst Ratings
Moderate Buy
5 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MRVI Stock 12 Month Forecast
Average Price Target
$9.50
▲(91.53% Upside)
| Highest Price Target$13.00 | Average Price Target$9.50 | Lowest Price Target$7.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wolfe Research
Initiated
11/14/24
Morgan Stanley
Reiterated
11/11/24
Craig-Hallum
Reiterated
11/08/24
Bank of America Securities
Reiterated
11/08/24
William Blair
Downgraded
11/08/24
RBC Capital
Reiterated
11/08/24
Robert W. Baird
Reiterated
11/07/24
Goldman Sachs
Reiterated
10/08/24
Wells Fargo
Assigned
09/06/24
Deutsche Bank
Assigned
08/09/24
UBS
$8.5→$11
Hold
121.77%
Upside
Reiterated
08/08/24
Maravai Lifesciences price target raised to $11 from $8.50 at UBSMaravai Lifesciences price target raised to $11 from $8.50 at UBS
Stifel Nicolaus
$10
Buy
101.61%
Upside
Reiterated
08/08/24
Stifel Nicolaus Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)
Jefferies
$8→$11
Buy
121.77%
Upside
Reiterated
06/03/24
Maravai Lifesciences price target raised to $11 from $8 at JefferiesMaravai Lifesciences price target raised to $11 from $8 at Jefferies
KeyBanc
―
Hold
―
Assigned
05/09/24
Analysts Offer Insights on Healthcare Companies: Editas Medicine (NASDAQ: EDIT), Arcus Biosciences (NYSE: RCUS) and Maravai Lifesciences Holdings (NASDAQ: MRVI)
Best Analysts Covering Maravai Lifesciences Holdings
Which Analyst Should I Follow If I Want to Buy MRVI and Sell After:
1 Month
xxx
Success Rate
11/18 ratings generated profit
Average Return
+1.93%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +1.93% per trade.
3 Months
xxx
Success Rate
8/20 ratings generated profit
Average Return
-1.42%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -1.42% per trade.
1 Year
Success Rate
3/13 ratings generated profit
Average Return
-27.32%
reiterated a buy rating 4 months ago
Copying Daniel Arias's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -27.32% per trade.
2 Years
xxx
Success Rate
1/13 ratings generated profit
Average Return
-53.78%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 7.69% of your transactions generating a profit, with an average return of -53.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MRVI Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
4
4
3
4
4
Buy
3
6
6
6
2
Hold
3
4
4
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
14
13
14
10
Each month's total comprises the sum of three months' worth of ratings.
MRVI Financial Forecast
MRVI Stock Forecast FAQ
What is MRVI’s average 12-month price target, according to analysts?
Based on analyst ratings, Maravai Lifesciences Holdings’s 12-month average price target is $9.50.
What is MRVI’s upside potential, based on the analysts’ average price target?
Maravai Lifesciences Holdings has 91.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MRVI a Buy, Sell or Hold?
Maravai Lifesciences Holdings has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 0 sell ratings.
What is Maravai Lifesciences Holdings’s price target?
The average price target for Maravai Lifesciences Holdings is $9.50. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $13.00 ,the lowest forecast is $7.00. The average price target represents 91.53% Increase from the current price of $4.96.
The highest analyst price target is $13.00 ,the lowest forecast is $7.00. The average price target represents 91.53% Increase from the current price of $4.96.
What do analysts say about Maravai Lifesciences Holdings?
Maravai Lifesciences Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of MRVI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.